Процентный доход Изменить Дата
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Chugai Pharma JPY 480M 465M 2024-06
Daiichi Sankyo JPY 9.96B 230M 2024-03
DBV Technologies USD -0.32 0.02 2024-09
Gilead Sciences USD 95M 0 2026-03
GlaxoSmithKline GBP 22M 96M 2026-03
Glaxosmithkline GBP 22M 4M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Novavax USD 303K 27K 2021-12
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sarepta Therapeutics USD 7M 1.74M 2026-03
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06